Surface and hemocompatibility studies of bi-soft segment polyurethane membranes

International Journal of Artificial Organs

Volumn 29, Issue 9, 2006, Pages 866-872

  Queiroz, D P ^a   Pinto, I M ^a   Besteiro, M C F ^b   Silva, A F M ^b   Gil, M H ^b   Guiomar, A J ^b,c   De Pinho, M N ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Blood oxygenator; Hemocompatibility; Hemolysis; Segmented polyurethane; Surface energy; Thrombosis

Indexed keywords

DISEASES; INTERFACIAL ENERGY; MEMBRANES; MONOMERS; PHASE SEPARATION; POLYBUTADIENES; POLYURETHANES;

10 MINUTES; BLOOD OXYGENATORS; BLOOD-MATERIAL; CONTACT TIME; HAEMOCOMPATIBILITY; HAEMOLYSIS; POLYBUTADIENE DIOL; SEGMENTED POLYURETHANES; SOFT SEGMENTS; THROMBOGENICITY;

BLOOD;

POLY(PROPYLENE OXIDE); POLYBUTADIENE DIOL; POLYMER; POLYPROPYLENE; POLYURETHAN; UNCLASSIFIED DRUG; UREA; URETHAN;

BLOOD COMPATIBILITY; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTACT ANGLE; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HYDROPHILICITY; HYDROPHOBICITY; MEMBRANE COMPONENT; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MEMBRANE TECHNOLOGY; PHASE SEPARATION; SURFACE PROPERTY; THROMBOGENICITY; THROMBOSIS;

EID: 33750706513     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900908     Document Type: Conference Paper

References (47)

1. Park JB, Lakes RS. Biomaterials. An introduction. 2nd Edition. New York: Plenum Press; 1992. p 280-91.
2. Rechavia E, Litvack F, Fishbien MC, Nakamura M, Eigler N. Biocompatibility of polyurethane-coated stents: tissues and vascular aspects. Cathet Cardiovasc Diagn 1998; 45: 202-7.
3. Burke JF, Didísheim P, Goupil D, Heller J, Kane JB, Katz JL, Kim WS, Lemon JE, Refojo MF, Robblee LS, Smith DC, Sweeney JD, Tompkins RG, Watson JT, Yager P, Yarmush ML. Application of materials in medicine and dentistry. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials science. An introduction to materials in medicine. New York: Academic Press; 1999. p 263-368.
4. Watanabe H, Hayashi J, Ohzeki H, Moro H, Sugawara M, Eguchi S. Biocompatibility of a silicone-coated polypropylene hollow fibre oxygenator in an in vitro model. Ann Thorac Surg 1999; 67: 1315-9.
5. Segers PA, Heida JF, de Vries I, Maas C, Boogaart AJ, Eilander S. Clinical evaluation of nine hollow fibre oxygenators. Perfusion 2001; 16: 95-106.
6. Nogawa A. The future of artificial lungs: an industry perspective. J Artif Organs 2002; 5: 211-5.
7. Wickramasinghe SR, Garcia JD, Han B. Mass and momentum transfer in hollow fibre blood oxygenators. J Memb Sci 2002; 208: 247-56.
8. Haworth WS. The development of the modern oxygenator. Ann Thorac Surg 2003; 76: S2216-9.
9. Bartels C, Gerdes A, Babin-Ebell J, Beyersdorf F, Boeken U, Doenst T, Feindt P, Heiermann M, Schlensack C, Sievers H. Cardiopulmonary bypass: evidence or experience based? J Thorac Cardiovasc Surg 2002; 124: 20-7.
10. Johnell M, Elgue G, Larson A, Stefan T, Suegbhn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg 2002; 124: 321-32.
11. Segesser LK. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003; 125: S90-1.
12. Wahba A, Philipp A, Behr R, Birnbaum DE. Heparin-coated equipment reduces the risk of oxygenators failure. Ann Thorac Surg 1998; 65: 1310-2.
13. Levy M, Hartman AR. Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not. Int J Cardiol 1996; 53 (Suppl 1): S81-7.
14. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999; 16: 342-50.
15. Janvier G, Baquey C, Roth C, Benillan N, Bélisle S, Hardy JF. Extracorporeal circulation, hemocompatibility, and biomaterials. Ann Thorac Surg 1996; 62: 1926-34.
16. Bamford CH, Al-Lamee G. Studies in polymer surface modification and grafting for medical uses: 2. Application to arterial blood filters and oxygenators. Polymer 1996; 37: 4885-9.
17. Anderson JM, Gristina G, Hanson SR, Harker LA, Johnson RJ, Merritt K, Naylor PT, Schoen FJ. Host reactions to biomaterials and their evaluation. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials science. An introduction to materials in medicine. New York: Academic Press; 1999. p 165-214.
18. Sun S, Yue Y, Huang X, Meng D. Protein adsorption on blood-contact membranes. J Memb Sci 2003; 222: 3-18.
19. Deppisch R, Storr M, Buck R, Göhl H. Blood material interactions at the surfaces of membranes in medical applications. Separation and Purification Technology 1998; 14: 241-54.
20. Keogh JR, Wolf MF, Overend E, Tang L, Eaton JW. Biocompatibility of sulphonated polyurethanes surfaces. Biomaterials 1996; 17: 1987-94.
21. Bernacca GM, Gulbransen MJ, Wilkinson R, Wheatley DJ. In vitro blood compatibility of surface-modified polyurethanes. Biomaterials 1998; 19: 1151-65.
22. Fujisawa N, Poole-Warren LA, Woodard JC, Bertram CD, Schindhelm K. A novel textured surface for blood-contact. Biomaterials 1999; 20: 955-62.
23. Chen KY, Kuo JF, Chen CY. Synthesis, characterization and platelet adhesion studies of novel ion-containing aliphatic polyurethanes. Biomaterials 2000; 21: 161-71.
24. Lin DT, Yuong TH, Fang Y. Studies on the effect of surface properties on the biocompatibility of polyurethanes membranes. Biomaterials 2001; 22: 1521-9.
25. Spijker HT, Graaff R, Boonstra PW, Busscher HJ, van Oeveren W. On the influence of flow conditions and the wettability on blood material interactions. Biomaterials 2003; 24: 4717-27.
26. Wilson DJ, Rhodes NP, Williams RL. Surface modification of a segmented poly(ether)urethane using a low-powered gas plasma and its influence on the activation of the coagulation system. Biomaterials 2003; 24: 5069-81.
27. Poussard L, Burel F, Couvercelle JP, Merhi Y, Tabrizian M, Bunel C. Hemocompatibility of new ionic polyurethanes: influence of carboxylic group insertion modes. Biomaterials 2004; 25: 3473-83.
28. Zhao C-T, Pinho MN. Design of polypropylene oxide/polybutadiene bi-soft segment urethane/urea polymer for pervaporation membranes. Polymer 1999; 40: 6089-97.
29. Queiroz DP, Gonçalves MC, Pinho MN. Tailoring of phase segregation structures in bi-soft segment urethane/urea polymer membranes. J Appl Polym Sci (In press).
30. Queiroz DP, do Rego AMB, de Pinho MN. Bi-soft segment polyurethane membranes: surface studies by X-ray photoelectron spectroscopy. J Membr Sci 2006; 281: 239-44.
31. Ferreira Marques MF, Gordo PM, Gil CL, de Lima AP, Queiroz DP, Pinho MN, Kajcsos ZS. Gas permeability and temperature-dependent free-volume studies in polyurethane membranes by positron lifetime and Doppler spectroscopy. Materials Science Forum 2004; 445-446: 289-91.
32. International Standards Organization (ISO). ISO 10993-4: 2002 - Biological evaluation of medical devices. Part 4: Selection of tests for interactions with blood. 2nd Edn. Geneva: ISO; 2002.
33. Rusanov AI, Prokhorov VA. Interfacial tensiometry. Vol. 3. Amsterdam: Elsevier; 1996. p 82-179.
34. Owens DK, Wendt RC. Estimation of the surface of free energy of polymers. J Appl Polym Sci 1969; 13: 1741-7.
35. Rabel W. Einige Aspekte der Benetzungstheorie und ihre Anwendung auf die Untersuchung und Veränderung der Oberflächeneigenschaften von Polymeren. Farbe Lack 1971; 77: 997-1006.
36. Kaelble DH. Dispersion-polar surface tension properties of organic solids. Journal of Adhesion 1970; 2: 66-88.
37. Kaelble DH. Physical chemistry of adhesion. New York: John Wiley and Sons; 1971.
38. American Society for Testing of Materials (ASTM). ASTM F 756-00 - Standard practice for assessment of hemolytic properties of materials. West Conshohocken, PA, USA: ASTM; 2000.
39. Imai Y, Nosé Y. A new method for evaluation of antithrombogenicity. J Biomed Mater Res 1972; 6: 165-72.
40. Allmér K, Hilborn PH, Hult A, Rånby B. Surface modification of polymers. V. Biomaterial applications. J Polym Sci [A1] 1990; 28: 173-83.
41. U.S. Pharmacopeia. Anticoagulant citrate dextrose solution. Rockville, MD, USA: USP, 1995; 23: 119.
42. Zwart A, van Assendelft OW, Bull BS, England JM, Lewis SM, Zijlstra WG. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemoglobincyanide standard (4th ed). J Clin Pathol 1996; 49: 271-4.
43. Van Assendelft OW, Buursma A, Zijlstra WG. Stability of haemoglobincyanide standards. J Clin Pathol 1996; 49: 275-7.
44. Moore GL, Ledford ME, Merydith A. A micromodification of the Drabkin assay for measuring plasma hemoglobin in the range of 5 to 2000 mg/dL. Biochem Med 1981; 26: 167-73.
45. Nojima K, Sanui K, Ogata N, Yui N, Kataoka K, Sakurai Y. Material characterization of segmented polyether poly(urethane-ures-amide)s and its implication in blood compatibility. Polymer 1987; 28: 1017-24.
46. Yiu N, Tanaka J, Sanui K, Ogata N, Kataoka K, Okano T, Sakurai Y. Characterization of the microstructure of poly(propylene oxide) segmented polyamide and its suppression of platelet adhesion. Polym J 1984; 16: 119-28.
47. Kajiyama T, Takahara A. Surface properties and platelet reactivity of segmented poly(etherurethanes) and poly(etherurethaneureas). J Biomater Appl 1991; 6: 42-71.